ReviewExpert review of cardiovascular therapy2016
Epidemiology of cardiovascular disease: recent novel outlooks on risk factors and clinical approaches.
Review in Expert review of cardiovascular therapy, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Effects of HIIT and MICT on cardiovascular risk factors in adults with overweight and/or obesity: A meta-analysis.PloS one · 2019Pooled it
- Combined clinical, metabolomic, and polygenic scores for cardiovascular risk prediction.European heart journal · 2025Article
- Psychological stress among hypertensive male patients in Jordan: prevalence and associated factors.BMC public health · 2024Article
- Accelerated DNA methylation age plays a role in the impact of cardiovascular risk factors on the human heart.Clinical epigenetics · 2023Article
- Metabolome Profiling in the Plasma of Dogs with Idiopathic Dilated Cardiomyopathy: A Multiplatform Mass-Spectrometry-Based Approach.International journal of molecular sciences · 2023Article
- Impact of Diet on Gut Microbiota Composition and Microbiota-Associated Functions in Heart Failure: A Systematic Review of In Vivo Animal Studies.Metabolites · 2022Review
- Screening and Interventions for Cardiovascular Disease Prevention in the Limpopo Province, South Africa: Use of the Community Action Model.Metabolites · 2022Article
- Cardiovascular Disease Risk Modeling for Astronauts: Making the Leap From Earth to Space.Frontiers in cardiovascular medicine · 2022Review
- The optimal WC cut-off points for the prediction of subclinical CVD as measured by carotid intima-media thickness among African adults: a cross-sectional study.BMC cardiovascular disorders · 2021Article
- Cardiovascular risk estimation in young patients with ankylosing spondylitis: A new model based on a prospective study in Constanta County, Romania.Experimental and therapeutic medicine · 2021Article
- Polygenic risk scores and the prediction of common diseases.International journal of epidemiology · 2020Article
- Article
- The novel inflammatory marker GlycA and the prevalence and progression of valvular and thoracic aortic calcification: The Multi-Ethnic Study of Atherosclerosis.Atherosclerosis · 2019Article
- Increase in the Arterial Velocity Pulse Index of Patients with Peripheral Artery Disease.Pulse (Basel, Switzerland) · 2018Article
- Prospective Study of Epigenetic Age Acceleration and Incidence of Cardiovascular Disease Outcomes in the ARIC Study (Atherosclerosis Risk in Communities).Circulation. Genomic and precision medicine · 2018Article
- Coronary flow reserve is predictive of the risk of cardiovascular death regardless of chronic kidney disease stage.Kidney international · 2018Article
- Quantitative Serum Nuclear Magnetic Resonance Metabolomics in Large-Scale Epidemiology: A Primer on -Omic Technologies.American journal of epidemiology · 2017Review
- A plant-based diet and animal protein: questioning dietary fat and considering animal protein as the main cause of heart disease.Journal of geriatric cardiology : JGC · 2017Article
- Role of renal transporters and novel regulatory interactions in the TAL that control blood pressure.Physiological genomics · 2017Review
- Cohort description: The Danish study of Functional Disorders.Clinical epidemiology · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
introductionCardiovascular (CVD) risk assessment with traditional risk factors (age, sex, blood pressure, lipids, smoking and diabetes) has remained relatively invariant over the past decades despite some inaccuracies associated with this approach. However, the search for novel, robust and cost-effective risk markers of CVD risk is ongoing. AREAS COVERED: A large share of the major developments in CVD risk prediction during the past five years has been made in large-scale biomarker discovery and the so called 'omics' - the rapidly growing fields of genomics, transcriptomics, epigenetics and metabolomics. This review focuses on how these new technologies are helping drive primary CVD risk estimation forward in recent years, and speculates on how they could be utilized more effectively for discovering novel risk factors in the future. Expert commentary: The search for new CVD risk factors is currently undergoing a significant revolution as the simple relationship between single risk factors and disease will have to be replaced by models that strive to integrate the whole field of omics into medicine.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.